| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |